Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “lung cancer”

A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6Terminated
NCT06091930Phase 1Updated Aug 18, 2026
Sponsor: Boehringer Ingelheim
Gastrointestinal Cancer · Lung Cancer · Pancreatic Cancer · Colorectal Cancer
Japan
Demographics of Lung Cancer in FemalesRecruiting
NCT07122245N/AUpdated Aug 18, 2026
Sponsor: Mansoura University Hospital
Lung Cancer
Egypt
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic CancerRecruiting
NCT03412877Phase 2Updated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Endocrine Tumors · Non-Small Cell Lung Cancer · Ovarian Cancer · Breast Cancer
United States
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung LiningRecruiting
NCT00242723N/AUpdated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Thoracic Cancers · Malignant Pleural Mesotheliomas NOS · Lung Cancer NOS · Esophageal Cancers NOS
United States
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisRecruiting
NCT01441089N/AUpdated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Prostate Cancer · Breast Cancer · Lung Cancer · Ovarian Cancer
United States
Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion MutationsRecruiting
NCT06514027Phase 2Updated Aug 18, 2026
Sponsor: BeBetter Med Inc
Non Small Cell Lung Cancer
China
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung CancerRecruiting
NCT07325136Phase 1, Phase 2Updated Aug 18, 2026
Sponsor: Bristol-Myers Squibb
Relapsed/Refractory Small Cell Lung Cancer
United States, China, Italy, Japan, Romania +1 more
Pilot Study of Biopsy Scanner for Evaluation of Bronchoscopic Small Biopsy Specimens to Determine AdequacyCompleted
NCT05393154N/AUpdated Aug 18, 2026
Sponsor: Aquyre Bioscience, Inc
Lung Cancer
United States
CYTALUX Dose Extension StudyNot Yet Recruiting
NCT07469202Phase 4Updated Aug 18, 2026
Sponsor: On Target Laboratories, LLC
Cancer in the Lung · Ovarian Cancer
Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung CancerRecruiting
NCT06457789NAUpdated Aug 18, 2026
Sponsor: Amsterdam UMC, location VUmc
NSCLC
Netherlands
A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological FeaturesActive Not Recruiting
NCT06564844Phase 3Updated Aug 18, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Brazil, Canada, Hong Kong, Japan +5 more
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsRecruiting
NCT06618287Phase 1, Phase 2Updated Aug 18, 2026
Sponsor: Bristol-Myers Squibb
Lung Cancer · Breast Cancer
United States, Australia, Canada, Chile, France +5 more
Data Collection of Standard Care and Evaluation of NHLBI Patients and DonorsEnrolling By Invitation
NCT04450927N/AUpdated Aug 18, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Wide Spectrum of Diseases · Hematologic Diseases
United States
Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening TrialActive Not Recruiting
NCT00339495N/AUpdated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Cancer · Death
United States
Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)Recruiting
NCT06809764N/AUpdated Aug 18, 2026
Sponsor: Daiichi Sankyo
Non-small Cell Lung Cancer
China
A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung CancerNot Yet Recruiting
NCT07771764Phase 2Updated Aug 18, 2026
Sponsor: First Affiliated Hospital of Fujian Medical University
ALK-positive Non Small Cell Lung Cancer
China
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)Recruiting
NCT06731907Phase 2Updated Aug 18, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Chile, Greece, Hungary, Israel +6 more
Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting
NCT00001823N/AUpdated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Synovial Cell Cancer · Melanoma · Colorectal Cancer · Lung Cancer
United States
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney CancerRecruiting
NCT00033137N/AUpdated Aug 18, 2026
Sponsor: National Cancer Institute (NCI)
Kidney Neoplasms · Kidney Cancer · Pneumothorax · FLCN Protein, Human
United States
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946Recruiting
NCT06616766Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Yuhan Corporation
NSCLC (Non-small Cell Lung Cancer) · Solid Tumor
United States, South Korea
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainRecruiting
NCT06500455Phase 3Updated Aug 17, 2026
Sponsor: NRG Oncology
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Metastatic Digestive System Carcinoma · Metastatic Lung Non-Small Cell Carcinoma
United States, Canada, Hong Kong, Ireland
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung CancerRecruiting
NCT07476287Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Small Cell Lung Cancer · Small Cell Lung Cancer ( SCLC ) · Transformed Small Cell Lung Cancer · Lung Neoplasms
United States, Brazil, China, France, Hong Kong +5 more
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruiting
NCT07222566Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Advanced Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Brazil, Canada +15 more
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruiting
NCT05463796N/AUpdated Aug 17, 2026
Sponsor: Dana-Farber Cancer Institute
Cancer Risk · Cancer Predisposition Syndrome · Hereditary Cancer Prediction · Childhood Cancer Survivors
United States
Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLCActive Not Recruiting
NCT03965468Phase 2Updated Aug 17, 2026
Sponsor: ETOP IBCSG Partners Foundation
Non-small Cell Lung Cancer · Stage IV · Oligometastasis
Italy, Netherlands, Spain, Switzerland

Previous page Next page